Cargando…

NFAT-Specific Inhibition by dNP2-VIVIT Ameliorates Autoimmune Encephalomyelitis by Regulation of Th1 and Th17

Nuclear factor of activated T cells (NFATs) is an important transcription factor for T cell activation and proliferation. Recent studies have highlighted the role of NFATs in regulating the differentiation of effector CD4 T helper (Th) subsets including Th1 and Th17 cells. Because controlling the ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hong-Gyun, Kim, Li-Kyung, Choi, Je-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849366/ https://www.ncbi.nlm.nih.gov/pubmed/31737742 http://dx.doi.org/10.1016/j.omtm.2019.10.006

Ejemplares similares

LRR domain of NLRX1 protein delivery by dNP2 inhibits T cell functions and alleviates autoimmune encephalomyelitis
por: Koo, Ja-Hyun, et al.
Publicado: (2020)

dNP2 is a blood–brain barrier-permeable peptide enabling ctCTLA-4 protein delivery to ameliorate experimental autoimmune encephalomyelitis
por: Lim, Sangho, et al.
Publicado: (2015)

Delivery of the VIVIT Peptide to Human Glioma Cells to Interfere with Calcineurin-NFAT Signaling
por: Ellert-Miklaszewska, Aleksandra, et al.
Publicado: (2021)

NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury
por: Xie, Zhi-yong, et al.
Publicado: (2021)

Alpinia oxyphylla Fruit Extract Ameliorates Experimental Autoimmune Encephalomyelitis through the Regulation of Th1/Th17 Cells
por: Huang, Kuo-Kuei, et al.
Publicado: (2019)

4-Ethylguaiacol modulates neuroinflammation and Th1/Th17 differentiation to ameliorate disease severity in experimental autoimmune encephalomyelitis
por: Weng, Wen-Tsan, et al.
Publicado: (2021)

Amelioration of Experimental autoimmune encephalomyelitis and DSS induced colitis by NTG-A-009 through the inhibition of Th1 and Th17 cells differentiation
por: Acharya, Suman, et al.
Publicado: (2018)

dNP2-ctCTLA-4 inhibits German cockroach extract-induced allergic airway inflammation and hyper-responsiveness via inhibition of Th2 responses
por: Lim, Sangho, et al.
Publicado: (2017)

Paeoniflorin Ameliorates Experimental Autoimmune Encephalomyelitis via Inhibition of Dendritic Cell Function and Th17 Cell Differentiation
por: Zhang, Han, et al.
Publicado: (2017)

Functional and Pathogenic Differences of Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis
por: Domingues, Helena S., et al.
Publicado: (2010)

BAFF Promotes Th17 Cells and Aggravates Experimental Autoimmune Encephalomyelitis
por: Zhou, Xiaohui, et al.
Publicado: (2011)

Rotating magnetic field ameliorates experimental autoimmune encephalomyelitis by promoting T cell peripheral accumulation and regulating the balance of Treg and Th1/Th17
por: Zhan, Tianying, et al.
Publicado: (2020)

Rifampicin attenuates experimental autoimmune encephalomyelitis by inhibiting pathogenic Th17 cells responses
por: Ma, Ke, et al.
Publicado: (2016)

Brown adipose tissue ameliorates autoimmune arthritis via inhibition of Th17 cells
por: Moon, Jeonghyeon, et al.
Publicado: (2020)

GRIM-19 Ameliorates Multiple Sclerosis in a Mouse Model of Experimental Autoimmune Encephalomyelitis with Reciprocal Regulation of IFNγ/Th1 and IL-17A/Th17 Cells
por: Moon, Jeonghyeon, et al.
Publicado: (2020)

Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis
por: Cummings, Matthew, et al.
Publicado: (2018)

Tolerogenic Dendritic Cells Generated with Tofacitinib Ameliorate Experimental Autoimmune Encephalomyelitis through Modulation of Th17/Treg Balance
por: Zhou, Yan, et al.
Publicado: (2016)

Alpha-tocopherol ameliorates experimental autoimmune encephalomyelitis through the regulation of Th1 cells
por: Xue, Haikuo, et al.
Publicado: (2016)

Kirenol Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Differentiation of Th1 and Th17 Cells and Inducing Apoptosis of Effector T Cells
por: Xiao, Juan, et al.
Publicado: (2015)

CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells
por: Chung, Chen-Yen, et al.
Publicado: (2016)

Carnosol Modulates Th17 Cell Differentiation and Microglial Switch in Experimental Autoimmune Encephalomyelitis
por: Li, Xing, et al.
Publicado: (2018)

Peptide 11R-VIVIT promotes fracture healing in osteoporotic rats
por: Hou, Changju, et al.
Publicado: (2021)

Prostaglandin I(2) Signaling Drives Th17 Differentiation and Exacerbates Experimental Autoimmune Encephalomyelitis
por: Zhou, Weisong, et al.
Publicado: (2012)

SKI Expression Suppresses Pathogenic Th17 Cell Response and Mitigates Experimental Autoimmune Encephalomyelitis
por: Li, Ping, et al.
Publicado: (2021)

CCR6 and CXCR6 Identify the Th17 Cells With Cytotoxicity in Experimental Autoimmune Encephalomyelitis
por: Hou, Lifei, et al.
Publicado: (2022)

Protection of Tregs, Suppression of Th1 and Th17 Cells, and Amelioration of Experimental Allergic Encephalomyelitis by a Physically-Modified Saline
por: Mondal, Susanta, et al.
Publicado: (2012)

Pien Tze Huang Alleviates Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Mice by Regulating Th1 and Th17 Cells
por: Qiu, Xuemei, et al.
Publicado: (2018)

Revisiting the Concept of Targeting NFAT to Control T Cell Immunity and Autoimmune Diseases
por: Lee, Jae-Ung, et al.
Publicado: (2018)

A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation
por: Guo, Wei, et al.
Publicado: (2015)

BJ-1108, a 6-Amino-2,4,5-trimethylpyridin-3-ol analogue, regulates differentiation of Th1 and Th17 cells to ameliorate experimental autoimmune encephalomyelitis
por: Kang, Youra, et al.
Publicado: (2017)

Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
por: Basler, Michael, et al.
Publicado: (2014)

MiR-384 Regulates the Th17/Treg Ratio during Experimental Autoimmune Encephalomyelitis Pathogenesis
por: Qu, Xuebin, et al.
Publicado: (2017)

STEAP4 expression in CNS resident cells promotes Th17 cell-induced autoimmune encephalomyelitis
por: Zhao, Junjie, et al.
Publicado: (2021)

Silybin Alleviates Experimental Autoimmune Encephalomyelitis by Suppressing Dendritic Cell Activation and Th17 Cell Differentiation
por: Yang, Huan-Li, et al.
Publicado: (2021)

The antimicrobial peptide cathelicidin drives development of experimental autoimmune encephalomyelitis in mice by affecting Th17 differentiation
por: Smith, Katie J., et al.
Publicado: (2022)

Chronic Toxoplasma gondii Infection Alleviates Experimental Autoimmune Encephalomyelitis by the Immune Regulation Inducing Reduction in IL-17A/Th17 Via Upregulation of SOCS3
por: Ham, Do-Won, et al.
Publicado: (2020)

Amelioration of experimental autoimmune encephalomyelitis by Ishige okamurae
por: Ahn, Meejung, et al.
Publicado: (2018)

CD4(+)T cell specific B7-H1 selectively inhibits proliferation of naïve T cells and Th17 differentiation in experimental autoimmune encephalomyelitis
por: Shi, Sheng-Jia, et al.
Publicado: (2017)

Amelioration of Experimental Autoimmune Encephalomyelitis by Anatabine
por: Paris, Daniel, et al.
Publicado: (2013)

CD73 is expressed by inflammatory Th17 cells in experimental autoimmune encephalomyelitis but does not limit differentiation or pathogenesis
por: Hernandez-Mir, Gerard, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_n0atb3pm89e8lo6rbmrjlidmpt